|
|
 |
|
Author Index
|
 |
|
 |
 |
|
|
| Or
|
 |
|
|
 |
 |
 |
Search results for: "D"
Results 31 - 40 of 1338 shown below
|
 |
 |
 |
Balin-Gauthier, D
D Balin-Gauthier, J-P Delord, M-J Pillaire, P Rochaix, J-S Hoffman, R Bugat, C Cazaux, P Canal and B C Allal
Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation
advance online publication, 2008-01-08 00:00:00.000;
doi:10.1038/sj.bjc.6604134
Abstract |
Full article
| PDF
|
Ball, D L
M Michael, A Wirth, D L Ball, M MacManus, D Rischin, L Mileshkin, B Solomon, J McKendrick and A D Milner
A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC
advance online publication, 2005-09-06 00:00:00.000;
doi:10.1038/sj.bjc.6602759
Abstract |
Full article
| PDF
|
Baralle, D
L Walker, D Thompson, D Easton, B Ponder, M Ponder, I Frayling and D Baralle
A prospective study of neurofibromatosis type 1 cancer incidence in the UK
advance online publication, 2006-06-20 00:00:00.000;
doi:10.1038/sj.bjc.6603227
Abstract |
Full article
| PDF
|
Barkauskas, D S
Z Tang, R Du, S Jiang, C Wu, D S Barkauskas, J Richey, J Molter, M Lam, C Flask, S Gerson, A Dowlati, L Liu, Z Lee, B Halmos, Y Wang, J A Kern and P C Ma
Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer
advance online publication, 2008-08-26 00:00:00.000;
doi:10.1038/sj.bjc.6604559
Abstract |
Full article
| PDF
|
Barnard, D R
K N Canfield, L G Spector, L L Robison, D Lazovich, M Roesler, A F Olshan, F O Smith, N A Heerema, D R Barnard, C K Blair and J A Ross
Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: a report from the Children's Oncology Group
advance online publication, 2004-11-02 00:00:00.000;
doi:10.1038/sj.bjc.6602223
Abstract |
Full article
| PDF
|
Barrow, D
H E Jones, J M W Gee, D Barrow, D Tonge, B Holloway and R I Nicholson
Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells
advance online publication, 2006-07-04 00:00:00.000;
doi:10.1038/sj.bjc.6603237
Abstract |
Full article
| PDF
|
Bateman, D N
D R Camidge, D L Stockton, S Frame, R Wood, M Bain and D N Bateman
Hospital admissions and deaths relating to deliberate self-harm and accidents within 5 years of a cancer diagnosis: a national study in Scotland, UK
advance online publication, 2007-02-13 00:00:00.000;
doi:10.1038/sj.bjc.6603617
Abstract |
Full article
| PDF
|
Bates, D O
R O Pritchard-Jones, D B A Dunn, Y Qiu, A H R Varey, A Orlando, H Rigby, S J Harper and D O Bates
Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
advance online publication, 2007-06-26 00:00:00.000;
doi:10.1038/sj.bjc.6603839
Abstract |
Full article
| PDF
A H R Varey, E S Rennel, Y Qiu, H S Bevan, R M Perrin, S Raffy, A R Dixon, C Paraskeva, O Zaccheo, A B Hassan, S J Harper and D O Bates
VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
advance online publication, 2008-03-18 00:00:00.000;
doi:10.1038/sj.bjc.6604308
Abstract |
Full article
| PDF
E S Rennel, E Waine, H Guan, Y Schüler, W Leenders, J Woolard, M Sugiono, D Gillatt, E S Kleinerman, D O Bates and S J Harper
The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice
advance online publication, 2008-03-18 00:00:00.000;
doi:10.1038/sj.bjc.6604309
Abstract |
Full article
| PDF
|
Beauseigle, D
M-A Forget, S Turcotte, D Beauseigle, J Godin-Ethier, S Pelletier, J Martín, S Tanguay and R Lapointe
The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types
advance online publication, 2007-01-23 00:00:00.000;
doi:10.1038/sj.bjc.6603579
Abstract |
Full article
| PDF
|
Beirne, D A
J M G Larkin, S A Hughes, D A Beirne, P M Patel, I M Gibbens, S C Bate, K Thomas, T G Eisen and M E Gore
A Phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma
advance online publication, 2006-12-05 00:00:00.000;
doi:10.1038/sj.bjc.6603503
Abstract |
Full article
| PDF
|
 |
 |
 |
|
|
 |
 |
 |
|
 |